Inventor
CHIANELLI DONATELLA
US16 patents
⚠️ This page may combine multiple inventors who share the name “CHIANELLI DONATELLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IRM LLC
5 patentsUS7678792B2Mar 16, 2010
Compositions and methods for modulating c-kit and PDGFR receptors
IRM LLC13 citations83
US7638523B2Dec 29, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC1 citations62
US7592349B2Sep 22, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC3 citations62
US7563894B2Jul 21, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC3 citations62
US7514447B2Apr 7, 2009
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
IRM LLC2 citations62
NOVARTIS AG
4 patentsUS10077240B2Sep 18, 2018
Compositions and methods for modulating farnesoid X receptors
NOVARTIS AG4 citations82
US11021446B2Jun 1, 2021
Compositions and methods for modulating farnesoid X receptors
NOVARTIS AG0 citations60
US10683271B2Jun 16, 2020
Compositions and methods for modulating farnesoid X receptors
NOVARTIS AG0 citations51
US10351576B2Jul 16, 2019
Fused tricyclic pyrazole derivatives useful for farnesoid X receptors
NOVARTIS AG0 citations37
CHIANELLI DONATELLA
3 patentsUS8288540B2Oct 16, 2012
2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
CHIANELLI DONATELLA20 citations82
US9682939B2Jun 20, 2017
Compositions and methods for modulating farnesoid X receptors
CHIANELLI DONATELLA3 citations70
US8278452B2Oct 2, 2012
Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
CHIANELLI DONATELLA0 citations39